Regulation of Gene Expression: Chemical Logic
A single E. coli cell decides, in about one second, whether to spend the energy to make β-galactosidase. This choice is made not by a nervous system but by a protein reading the shape of a small molecule. This is the essence of gene regulation: allosteric proteins convert a chemical signal (a sugar, a metabolite, a hormone) into a physical change in DNA-binding affinity. This change in turn alters RNA polymerase's probability of transcribing a gene. There is no magic here, only thermodynamics. It relies on binding equilibria, cooperativity, and free-energy coupling. This coupling links a small-molecule pocket and a DNA-recognition surface. This is exactly the same chemical vocabulary used to describe Enzyme Kinetics: Michaelis-Menten and Beyond or hemoglobin oxygen binding. Gene regulation matters because genomes are static but environments are not. A bacterium encountering lactose but no glucose must act fast. It must synthesize a permease and a hydrolase within minutes. A liver cell facing a fasting signal must induce gluconeogenic enzymes. At the same time it must shut down glycolytic ones. A developing embryo must turn on even-skipped in seven precise stripes. It does this using the same Bicoid and Hunchback proteins. These proteins diffuse through every nucleus. In every case the logic is the same three-part chemical circuit. There is a sensor (allosteric ligand-binding domain). There is a DNA-binding module (helix-turn-helix, zinc finger, leucine zipper, or basic-helix-loop-helix). There is also an effector interface. This effector interface is a surface that contacts RNA polymerase or the Mediator complex. It raises or lowers the rate of transcription initiation. This is built on the machinery described in Promoters, Initiation, and Termination of Transcription. The big picture is combinatorial. Genomes do not encode one regulatory protein per gene. Instead they build enormous specificity from a modest number of transcription factors. These factors are used in combination, the way four musical notes make a chord. The lac operon is controlled by two proteins (LacI and CAP). These respond to two signals (allolactose and cAMP). This produces four logical states. A human gene promoter may integrate binding sites for a dozen factors. Each factor is present or absent, each partially occupied. This produces an analog output that looks almost continuous. Understanding this requires no new physics. It relies on the equilibrium binding framework already used for oxygen–hemoglobin and substrate–enzyme interactions. The innovation is architectural, not thermodynamic. This article builds the chemical logic from the ground up. It covers the equilibrium binding of repressors and activators to operator DNA. It also covers the allosteric switch that ligands trigger. It examines the mechanistic wiring of the lac and trp operons as worked exemplars. It also covers the combinatorial arithmetic that eukaryotic enhancers use. This arithmetic integrates many inputs into one transcriptional output. It sets the stage for Epigenetics and Chromatin-Level Control. There, the same logic is layered onto a chromatin template.
- Repressors and activators are allosteric proteins: a small-molecule or protein ligand binding at one site changes DNA-binding affinity at a distant site, exactly like O₂ binding shifts hemoglobin's conformation.
- Operon architecture (negative/positive control) is built from equilibrium binding constants; occupancy of an operator follows a Hill-type binding isotherm, not an on/off switch.
- The lac operon integrates two independent chemical inputs — allolactose (relieves repression) and cAMP–CAP (provides activation) — giving AND-like logic so the operon turns on only when lactose is present and glucose is scarce.
- The trp operon uses negative feedback (repression by tryptophan-bound TrpR) plus attenuation, a distinct mechanism using ribosome position on nascent RNA to control transcription termination.
- Eukaryotic enhancers achieve combinatorial control through cooperative binding of multiple transcription factors and physical looping to a core promoter via Mediator, turning binding-site arithmetic into a continuous transcriptional dial.
- Free energy of DNA-binding specificity comes from a limited chemical vocabulary — hydrogen bonds to base edges in the major/minor groove, base-stacking, and phosphate-backbone electrostatics — read out by α-helices (HTH, zinc finger) inserted into the groove.
- Key idea: gene regulation is allosteric ligand-binding thermodynamics wired to transcription-initiation kinetics, with specificity built from a small structural alphabet (HTH, zinc finger, bZIP) and complexity built by combining binding sites, not by inventing new chemistry.
Where this lives today
The chemical logic of operons is now industrial infrastructure. IPTG (isopropyl β-D-1-thiogalactopyranoside), a non-hydrolyzable allolactose mimic, is the standard inducer used across biotechnology to switch on recombinant protein expression from lac-based promoters (T7lac, tac, trc) in essentially every academic and industrial E. coli expression system, from insulin manufacturing to structural-biology sample prep. The Tet-Off/Tet-On system, built from the bacterial TetR repressor and its operator, has been re-engineered into a doxycycline-responsive transcriptional switch used throughout mammalian cell biology and mouse genetics to achieve temporally controlled gene expression — a direct transplant of prokaryotic allosteric logic into eukaryotic chromatin. Zinc-finger arrays and TALEs (transcription activator-like effectors), which use the same major-groove-reading chemical strategy as natural zinc-finger transcription factors, were engineered into programmable DNA-binding modules for gene therapy and genome editing before being partly superseded by RNA-guided CRISPR-Cas systems — but the fusion architecture (DNA-binding domain + effector domain) pioneered by natural transcription factors remains the design template for dCas9-based transcriptional activators (CRISPRa) and repressors (CRISPRi) used today in functional genomic screens. In medicine, drugs that exploit allosteric transcription-factor switches include tamoxifen, which locks the estrogen receptor (a nuclear hormone receptor built on the same ligand-sensor/DNA-binding-domain architecture as bacterial regulators) into a conformation that recruits corepressors instead of coactivators, and glucocorticoid analogs (dexamethasone) that activate the glucocorticoid receptor's DNA-binding function for anti-inflammatory therapy. The combinatorial-control principle scales directly into eukaryotic enhanceosome biology — the interferon-β enhanceosome, built from NF-κB, IRF, and ATF-2/c-Jun binding cooperatively to a ~55-bp enhancer, is a textbook demonstration that the same product-of-occupancies arithmetic derived here for the lac operon governs antiviral gene induction in human cells, and it is precisely this layer of combinatorial transcription-factor logic that is further modulated by nucleosome positioning and histone modification, the subject taken up in Epigenetics and Chromatin-Level Control.
Ask the tutor: How would the fold-repression calculation change if the repressor itself were also subject to allosteric activation by a second, independent ligand?
The physical picture — allostery, operators, and combinatorial logic
A repressor protein has (at minimum) two binding sites that communicate: a DNA-binding domain that recognizes a specific operator sequence, and an effector-binding site that binds a small molecule (inducer or corepressor). These sites are typically 2–4 nm apart on the protein but are thermodynamically coupled — ligand binding at one site changes the free energy of the conformational ensemble sampled at the other, exactly the conformational selection / induced fit duality seen in enzymes. For LacI, the apo (ligand-free) tetramer has its DNA-binding "headpieces" positioned for high-affinity, base-specific contact with the operator; when allolactose binds the core domain, a rigid-body rotation of the subunits pries the headpieces into a geometry incompatible with operator DNA, dropping the affinity roughly 1000-fold. Recognition of the operator itself is chemical, not magical: DNA is read without unwinding the duplex, using the major groove, whose exposed edges of A·T and G·C base pairs display a unique pattern of hydrogen-bond donors and acceptors (unlike the minor groove, which is nearly symmetric between the four bases). A helix-turn-helix (HTH) motif inserts one α-helix (the "recognition helix") into the major groove so that its side chains — Asn, Gln, Arg, Lys — hydrogen-bond to specific base edges, while a second helix packs against the DNA backbone for register and stability. Different structural solutions to the same chemical problem include the zinc finger (a Zn²⁺ ion tetrahedrally coordinated by two Cys and two His holds a compact ββα fold whose α-helix reads the major groove; fingers are strung in tandem arrays to read longer sequences, the logic later exploited by zinc-finger nucleases) and the basic leucine zipper (bZIP), in which two long α-helices dimerize via a leucine-lined coiled-coil while their N-terminal basic extensions splay apart into a "scissor" shape that clamps the major groove from both sides of a palindromic site — the structural basis of AP-1, C/EBP, and CREB. Operator occupancy is not binary. At any instant, the fraction of operators bound by repressor is set by a Langmuir-type binding equilibrium modulated by cooperativity — polymerase does not see "off" or "on" but a continuously graded promoter occupancy that translates into a continuously graded transcription rate. Combinatorial control layers multiple such equilibria: a positive activator (like CAP) increases the local concentration of RNA polymerase at the promoter (or stabilizes an open complex) while a repressor (like LacI) sterically excludes polymerase or physically loops the DNA to block access. The overall transcription rate is a product (for independent inputs) or a more complex expression (for cooperative inputs) of these individual occupancy terms — turning a handful of binding equilibria into combinatorial logic gates.
The core ideas — equilibrium binding, allostery, and combinatorial occupancy
The fraction of operator sites occupied by a repressor R at free concentration obeys simple bimolecular equilibrium:
where:
- — fraction of operator DNA bound by repressor (occupancy, 0 to 1)
- — free repressor concentration in the cell (mol/L)
- — dissociation constant of the repressor–operator complex (mol/L)
Reading: when the operator is saturated with repressor (, gene off); when the operator is free (, gene expressible). for LacI–operator is extraordinarily tight, roughly , which is why a handful of LacI tetramers (~10 per cell) suffice to keep the operon almost completely repressed. The allosteric switch itself is governed by ligand-linked equilibrium, most simply captured by a two-state (MWC-like) model in which the repressor exists in a DNA-binding-competent state and a DNA-binding-incompetent state , with inducer binding preferentially to :
where:
- — allosteric equilibrium constant in the absence of ligand
- — dissociation constants of inducer for the and states ()
- — number of ligand-binding sites per oligomer (4 for LacI tetramer)
- — free inducer concentration
Reading: because , increasing inducer concentration preferentially stabilizes , pulling the whole population toward the DNA-releasing conformation with a steepness set by — the molecular origin of the sharp, switch-like induction curves seen for the lac operon, mechanistically identical to the Monod-Wyman-Changeux description of hemoglobin cooperativity. For combinatorial promoters with independent activator/repressor inputs, if each transcription factor's contribution to polymerase recruitment is captured by an independent free-energy term , the overall rate of transcription initiation relative to a reference (unregulated) rate follows a statistical-thermodynamic sum:
where:
- — statistical weight for RNA polymerase transcribing in configuration (1 if polymerase is present and active, else contributes to the denominator only)
- — total interaction free energy of configuration (sum of individual factor–DNA and factor–factor cooperative terms)
- — thermal energy (0.616 kcal/mol at 37 °C)
Reading: this is precisely the grand-canonical partition-function approach used for ligand binding to multi-site proteins; each additional transcription factor binding site multiplies the number of accessible states, and cooperative factor–factor contacts ( cross-terms) let the output rate rise super-linearly with the number of occupied sites — the molecular basis of enhancer "AND-gate" and synergy behavior in eukaryotic promoters.
Goal: derive how many-fold a repressor suppresses transcription, and show how this connects measured and repressor copy number to the observed ~1000-fold repression of lacZ.
Step 1 — Define the two-state promoter. Treat the operator as either free (polymerase can bind, rate ) or repressor-bound (transcription blocked). The steady-state mRNA synthesis rate is proportional to the unoccupied fraction:
This follows directly from the equilibrium above by substitution: .
Step 2 — Compare repressed and induced states. In the repressed state, free repressor concentration is high, ; in the fully induced state, essentially all repressor is sequestered as the R\ (non-DNA-binding) conformation, so the effective* free repressor able to bind operator collapses to a small residual . The fold-repression is the ratio of unoccupied fractions:
which simplifies, using (tight, saturating repression) and (essentially free operator when induced), to:
Step 3 — Insert numbers. E. coli has about 10 tetramers of LacI per cell; cell volume is about L, giving:
With M for the strongest operator (O1) in the absence of inducer:
Step 4 — Reconcile with the observed ~1000-fold repression. The measured in vivo repression is smaller (~1000- to 2000-fold) than this idealized ratio because (a) the operator is in equilibrium not only with free repressor but with nonspecific DNA sites that titrate most of the repressor away from O1, effectively raising the apparent free needed, and (b) DNA looping between O1 and the auxiliary operators O2/O3 (see below) contributes additional stabilization that is already folded into the empirically measured "effective" rather than the isolated-operator value. The qualitative conclusion survives intact: sub-picomolar operator affinity combined with only ~10 repressor molecules per cell is sufficient to produce robust, near-total repression — this is the chemical reason bacteria can afford to make regulators in vanishingly small copy number.
Limiting case: if (infinitely tight repressor), fold-repression : the gene is perfectly OFF whenever any repressor is free — consistent with a molecular on/off switch as shrinks well below cellular repressor concentration.
Go deeper · Derivation B · 2 minDNA looping and auxiliary operators: cooperative binding raises effective affinity
Goal: show quantitatively how a second, weaker operator (O3) cooperates with the main operator (O1) through DNA looping to multiply repression well beyond what O1 alone would achieve — the physical chemistry behind why lacI deletions of O2/O3 alone still partially derepress the operon.
Step 1 — Two operators, one repressor tetramer. LacI is a tetramer with two DNA-binding "dimeric" head-modules, each capable of engaging a separate operator. If both O1 (strong, ) and O3 (weak, ) are bound simultaneously by the same tetramer, the DNA between them (92 bp) is looped out. The two binding events are not independent: forming the loop costs an entropic penalty (unfavorable, from restricting the conformational freedom of the intervening DNA) but gains a favorable effective concentration boost, because once one head is bound at O1, the second head's local concentration near O3 is far higher than bulk solution — this is the same "effective molarity" argument used for intramolecular catalysis.
Step 2 — Write the coupled equilibrium. Define the overall dissociation constant for the looped, doubly-bound complex in terms of the individual site constants and an effective concentration term (units of molarity) that captures the entropic cost of loop closure:
Step 3 — Numbers. Measured values: M (isolated O1), M (isolated O3, ~100-fold weaker), and M for looped DNA of this length and this degree of intervening flexibility (a typical value inferred from in vitro looping assays on ~100 bp spacers with intervening protein-induced bending by CAP). Then:
Step 4 — Interpret. The apparent affinity of the looped, tetramer-bridged complex ( M) is five orders of magnitude tighter than O1 alone ( M) — even though O3 by itself is a mediocre binding site. This is why deleting O3 (or O2) individually raises basal expression 2- to 4-fold rather than fully derepressing the operon: the loop is a cooperative bonus layered on top of, not a replacement for, the dominant O1 interaction. It is also why CAP, which bends DNA by nearly 90° upon binding its own site between O1 and the promoter, can help nucleate the loop geometrically, coupling activation and repression modules mechanically as well as chemically.
Limiting case: as (operators too far apart or DNA too stiff to loop, so juxtaposition confers no advantage), divided by a huge number, which technically diverges in this toy formula — the physically correct interpretation is that when looping is geometrically prohibited, the coupled term drops out entirely and repression reverts to the single-operator limit, , exactly the single-operator result derived above.
Worked examples
Example 1 (foundational) — Occupancy of a single operator at physiological repressor concentration. Suppose a hypothetical repressor R has M for its operator, and the free intracellular concentration of R is M (asymmetric, non-round numbers chosen deliberately). Find the fractional occupancy of the operator. Using :
So 80% of operators are repressor-bound at steady state — the gene is mostly, but not completely, off. The fraction transcriptionally available is , i.e., the gene fires at 20% of its unrepressed rate. Limiting check: if (repressor degraded or genetically deleted), and the promoter runs at its intrinsic, fully derepressed rate — consistent with classical lacI⁻ constitutive mutants, which express lacZ regardless of inducer.
Example 2 (applied) — Combinatorial logic of the lac operon under four physiological conditions. Model lac transcription rate as the product of two independent occupancy terms, activator (CAP-cAMP) occupancy and repressor-free fraction :
Take illustrative but chemically reasonable numbers: with glucose present, cAMP is low, giving ; with glucose absent, cAMP is high (adenylate cyclase is disinhibited), giving . With lactose absent, allolactose is essentially zero and LacI occupies the operator tightly, ; with lactose present, allolactose induces LacI release, . Four combinations:
Only the last condition — glucose scarce and lactose present — gives a large output (85.5% of maximal rate); the other three combinations give at most a few percent. This reproduces the qualitative AND-gate behavior of the operon (diauxic growth: glucose is always used first) from nothing but the product of two independent binding equilibria. Limiting check: if CAP were absent entirely ( at all glucose levels, mimicking a crp⁻ mutant), the rate collapses to zero in every column regardless of lactose — matching the experimental observation that crp mutants show severely reduced, glucose-insensitive, near-constitutively-low lac expression.
Example 3 (exam/competition level) — Attenuation arithmetic in the trp operon. The trp leader transcript folds into one of two mutually exclusive hairpins depending on ribosome position on a short leader peptide containing two consecutive Trp codons. Region 1 pairs with region 2 (favoring a pause/antitermination path) or region 3 pairs with region 4 (forming a Rho-independent terminator hairpin, a U-rich run following a GC-rich stem, exactly the terminator architecture described in Promoters, Initiation, and Termination of Transcription); alternatively region 2 pairs with region 3 (antiterminator), which is mutually exclusive with the 3:4 terminator. Suppose translation of the leader peptide proceeds with a per-codon elongation probability that becomes rate-limiting only at the two Trp codons when charged tRNA^Trp is scarce. Let be the probability that the ribosome stalls at the first Trp codon (tryptophan starvation, low charged-tRNA^Trp), and the probability it reads through without pausing (tryptophan abundant). A stalled ribosome physically occupies region 1, preventing 1:2 pairing, forcing 2:3 antiterminator formation, so transcription reads through into trpE. A ribosome that reads through unimpeded covers region 2 as well, freeing 3:4 to form the terminator, halting transcription. If under moderate starvation (asymmetric, chosen to avoid a trivial 0.5 split), the fraction of transcripts that read through into the structural genes is:
while under Trp-replete conditions falls to, say, (ribosome almost never stalls, terminator almost always forms), giving:
The ratio of transcriptional output between starved and replete conditions is:
Attenuation alone can therefore modulate trp operon output ~35- to 40-fold — layered on top of the ~70-fold range achieved by TrpR-mediated repression (holo-TrpR, tryptophan-bound, binds the operator; apo-TrpR does not) — so the two mechanisms multiply, giving combined regulatory range on the order of -fold, matching the very large dynamic range measured for trp operon expression between full starvation and tryptophan excess. Limiting check: as (ribosome always stalls, complete starvation), : every transcript reads through, the biologically sensible limit when the cell desperately needs to make more tryptophan.
Limiting cases, scope & common traps
| Regime / Case | What happens | Why (chemical reason) |
|---|---|---|
| Operator saturated, gene off | Equilibrium driven fully toward RO complex | |
| Operator free, gene on | Repressor dissociates faster than it rebinds a competing site | |
| Inducer | All repressor in R* state, | MWC equilibrium fully shifted; pulls population to non-binding conformation |
| No cooperativity between operators () | Looping term vanishes | No entropic/geometric benefit to simultaneous binding; system reverts to single-site |
| Independent activator + repressor | Rate = product of occupancies | No direct physical/allosteric coupling between the two proteins |
| Cooperative activators (enhanceosome) | Rate rises super-linearly with site number | Protein–protein contacts add favorable cross-terms, not just additive occupancy |
| Attenuation, (Trp replete) | Nearly all transcripts terminate early | Ribosome reads through Trp codons fast, frees 3:4 terminator hairpin |
| Attenuation, (Trp starved) | Nearly all transcripts read through | Ribosome stalls at Trp codons, forces 2:3 antiterminator |
The chemist behind it
The molecular logic of gene regulation was established by François Jacob and Jacques Monod, working at the Institut Pasteur in the 1950s–60s alongside Arthur Pardee on the landmark PaJaMo experiments (1959) that first demonstrated a diffusible cytoplasmic repressor controlling β-galactosidase synthesis. Monod, trained as a biochemist studying bacterial growth kinetics (his own doctoral work concerned diauxic growth — bacteria consuming glucose before lactose, the very phenomenon later explained mechanistically by CAP/cAMP), brought rigorous kinetic and thermodynamic thinking to a field then dominated by pure genetics. Jacob, a surgeon turned geneticist after World War II, contributed the genetic dissection that distinguished cis-acting operator mutations from trans-acting repressor mutations — the operational definition still used to classify regulatory elements today. Their 1961 paper, "Genetic Regulatory Mechanisms in the Synthesis of Proteins," introduced the words operon, operator, and repressor into the scientific vocabulary and proposed — correctly, and years before any repressor protein was purified — that a repressor binds operator DNA directly, blocking RNA synthesis. Walter Gilbert and Benno Müller-Hill isolated the lac repressor protein biochemically in 1966, confirming the Jacob-Monod model at the molecular level and showing it bound specifically to operator DNA with the very high affinity later measured precisely by nitrocellulose filter-binding assays.
Origins · 1 minFrançois Jacob and Jacques Monod and how this was discovered
Jacob and Monod shared the 1965 Nobel Prize in Physiology or Medicine (with André Lwoff) for discoveries concerning genetic control of enzyme and virus synthesis. Their operon model — built from bacterial genetics, not structural biology, since no repressor structure existed yet — correctly predicted the existence of allosteric proteins whose ligand-binding and DNA-binding functions are physically coupled, a concept Monod generalized in his 1963 work on allostery with Jeffries Wyman and Jean-Pierre Changeux (the MWC model), unifying gene regulation and enzyme cooperativity under one thermodynamic framework.
Why is the lac repressor a tetramer rather than a single polypeptide?
The tetrameric architecture allows LacI to engage two operators simultaneously (typically O1 plus O2 or O3), looping the intervening DNA and gaining a large increase in effective affinity through the same "effective concentration" logic used in intramolecular catalysis. Each dimeric half of the tetramer independently recognizes one operator sequence via its N-terminal headpiece HTH motif, while the C-terminal core domains associate into a four-helix bundle that holds the two dimers together and also houses the allolactose-binding pockets. This architecture converts a modest single-site affinity into an extremely tight, cooperative, loop-stabilized repression complex using only ~10 protein copies per cell — a chemically economical solution to achieving near-total repression without needing enormous repressor concentrations.
How does glucose actually lower cAMP levels inside the cell?
Glucose transport through the phosphotransferase system (PTS) generates a phosphorylated intermediate, EIIA^Glc, whose phosphorylation state is coupled to glucose flux. When glucose is abundant, EIIA^Glc is predominantly dephosphorylated (having donated its phosphate to incoming glucose), and dephosphorylated EIIA^Glc does not stimulate adenylate cyclase, so cAMP synthesis stays low. When glucose is scarce, EIIA^Glc accumulates in its phosphorylated form, which allosterically activates adenylate cyclase, raising cAMP. Elevated cAMP then binds CAP, driving the allosteric conformational change that lets CAP's DNA-binding domain engage its site and contact RNA polymerase's α-subunit CTD, exactly analogous to how allolactose triggers the LacI conformational switch in the opposite direction.
Is DNA looping in the lac operon actually required for full repression, or just a fine-tuning mechanism?
It is a substantial fine-tuning and stabilization mechanism rather than an absolute requirement. Strains deleted for both auxiliary operators (O2 and O3), leaving only O1, still show measurable repression — LacI can still bind O1 directly with its very high intrinsic affinity — but basal expression rises several-fold compared with wild type, and the kinetics of repressor rebinding after induction is slowed. The looped, doubly-bound state is best understood as adding several kcal/mol of extra stabilization free energy on top of the dominant single-operator interaction, sharpening the OFF state and improving the robustness of repression against fluctuations in repressor copy number, rather than being the sole source of repression.
Why do eukaryotic promoters need so many more transcription factors than bacterial operons?
Bacterial genomes are compact and operons are typically regulated by one or two dedicated proteins responding to one or two chemical signals, sufficient because bacterial gene expression programs are relatively few and directly metabolic. Eukaryotic genomes must specify precise expression patterns across hundreds of cell types and developmental stages using a comparatively limited transcription-factor repertoire, so specificity is achieved combinatorially: a gene's enhancer integrates binding sites for many factors, and only the correct combination — present simultaneously in a given cell type — produces strong, cooperative, Mediator-dependent recruitment of RNA polymerase II. This also explains why eukaryotic promoters commonly work with enhancers located many kilobases away, requiring DNA looping (analogous in principle to lac operator looping but on a much larger genomic scale) to bring bound factors into contact with the core promoter and Mediator complex.
Does allolactose bind the same site on LacI as IPTG?
Yes, essentially the same core ligand-binding pocket, which is why IPTG functions as a faithful laboratory surrogate for the natural inducer. Allolactose is a transglycosylation byproduct generated by β-galactosidase itself from a small fraction of lactose molecules (β-galactosidase converts most lactose to glucose and galactose, but occasionally rearranges the bond to form allolactose instead), creating a built-in positive-feedback loop: a little leaky LacZ expression produces allolactose, which further induces more LacZ. IPTG is preferred experimentally because, unlike allolactose, it is not metabolized by β-galactosidase, so its intracellular concentration (and hence induction level) stays constant over the course of an experiment rather than being consumed.
How does attenuation differ mechanistically from repression, given that both reduce trp operon output?
Repression (via TrpR) acts at the level of transcription initiation: tryptophan-bound holo-TrpR binds the operator and blocks RNA polymerase from ever starting a transcript. Attenuation acts after initiation has already occurred, at the level of premature transcription termination within the first ~140 nucleotides of the leader transcript, and its molecular switch is not a protein-DNA equilibrium at all but the physical position of a translating ribosome on the nascent RNA relative to two competing hairpin structures. Because bacterial transcription and translation are coupled (no nuclear membrane separates them), the ribosome's speed through the leader peptide — set by how much charged tRNA^Trp is available — directly gates whether RNA polymerase, transcribing just ahead of it, encounters a terminator hairpin or reads through. The two mechanisms are chemically independent but multiply together to give a much larger dynamic range than either alone.
Can a single transcription factor act as both an activator and a repressor?
Yes — this is common and depends entirely on the position of its binding site relative to the promoter and on which surface of the protein contacts RNA polymerase or Mediator in a given context. CAP itself represses a small number of genes (such as the gal operon under certain arrangements) when its binding site is positioned so that CAP occludes rather than assists polymerase binding, even though at lac it activates. Nuclear hormone receptors similarly recruit corepressor or coactivator complexes depending on which ligand occupies their binding pocket (agonist versus antagonist) and on the surrounding chromatin context, which is precisely why drugs like tamoxifen can act as an estrogen receptor antagonist in breast tissue while behaving as a partial agonist in the endometrium — the DNA-binding domain and dimerization interface are identical, but the conformational outcome of ligand binding differs by context.